A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Married tax penalty set to end
US sends large delegation to Davos
The US needs to clear debts before leaving WHO
Bern police use pepper spray on Iranian protestors
Teen killed at train yard
UBS head planning to leave next year - report
